METASTATIC PANCREATIC ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for pancreatic cancer shows promise in early trial
Disease control TerminatedThis study looked at whether adding a precise type of radiation (stereotactic body radiation therapy) to standard chemotherapy could help people with pancreatic cancer that has spread to only a few places in the body. The goal was to see if the combination could better control tu…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
Experimental cancer shot trial halted after just two patients
Disease control TerminatedThis early-stage trial tested two immune-boosting drugs injected directly into tumors for people with stage IV pancreatic cancer or other advanced solid tumors (excluding melanoma). The goal was to see if the combination could shrink tumors or slow their growth. However, the stud…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Pancreatic cancer drug combo study ends early
Disease control TerminatedThis study tested a new drug called NIS793 combined with standard chemotherapy (FOLFIRINOX) for people with advanced pancreatic cancer that had spread. The goal was to see if the combination was safe and could help shrink tumors enough for surgery. Only 4 people took part before …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 20, 2026 11:57 UTC